Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 3, 2001, Pages 1072-1077

  Manole, Diana ^c   Schildknecht, Beatrice ^c   Gosnell, Bernadett ^c   Adams, Eric ^a   Derwahl, Michael ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b St Hedwig Hospital   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIN D1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESTROGEN ACTIVITY; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MALE; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID TUMOR; TUMOR GROWTH;

ADENOCARCINOMA; BLOTTING, WESTERN; CELL DIVISION; CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GOITER; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID GLAND; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0035048542     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.3.1072     Document Type: Article

References (47)

1. Endogenous hormones as a major factor in human cancer
2. A population-based case-control study of thyroid cancer
3. Thyroid cancer among young women related to prior thyroid disease and pregnancy history
4. Incidence of thyroid cancer in women in relation to previous exposure to radiation therapy and history of thyroid disease
5. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort
6. Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma
7. Expression of the estrogen receptor in human thyroid neoplasms
8. Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissue
9. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells
10. Steroid receptor family: Structure and functions
11. The steroid and thyroid hormone receptor superfamily
12. Protein tyrosine phosphorylation and estradiol action
13. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
14. Estrogen stimulates delayed mitogen-activated protein kinase activity in human endothelial cells via an autocrine loop that involves basic fibroblast growth factor
15. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
16. Mode of estrogen action on cell proliferative kinetics in CAMA-1 cells. I. Effect of serum and estrogen
17. 1 phase population
18. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells
19. 17β-Estradiol induces cyclin D1 gene transcription, p36D1-34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells
20. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation
21. Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: Growth inhibition by cAMP
22. Establishment of a highly differentiated thyroid cancer cell line of Hurthle cell origin
23. Suppression of thyrotropin receptor-G protein-phospholipase C coupling by activation of protein kinase C in thyroid carcinoma cells
24. The protective effects of estrogen on the cardiovascular system
25. An abnormal splice donor site in one allele of the thyroid peroxidase gene in FRTL5 rat thyroid cells introduces a premature stop codon: Association with the absence of functional enzymatic activity
26. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
27. Pathogenesis and treatment of multinodular goiter
28. Molecular pathogenesis of tumors of thyroid follicular cells
29. Growth factors in breast cancer
30. Oncogenes as clinical prognostic indicators
31. Steroids, growth factors, and cell cycle controls in breast cancer
32. The retinoblastoma protein and cell cycle control
33. Cyclin D and oncogenesis
34. Molecular pathogenesis of thyroid cancer: The significance of oncogenes, tumor suppressor genes, and genomic instability
35. Clinical review 101: Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors
36. Excessive activation of tyrosine kinases leads to inhibition of proliferation in a thyroid carcinoma cell line
37. Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras
38. Differential effects of protein kinase A on Ras effector pathways
39. Molecular basis of thyroid cancer
40. The epidermal growth factor
41. Phosphorylation of mitogen-activated protein kinases is involved in the epidermal growth factor and phorbol ester, but not in the thyrotropin/cAMP, thyroid mitogenic pathway
42. The molecular and neuroanatomical basis for estrogen effects in the central nervous system
43. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor
44. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry
45. Identification of a specific pattern of immediate-early gene activation induced by estrogen during mitogenic stimulation uterine cells
46. Mechanism of estrogen activation of c-myc oncogene expression
47. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induces mitogenesis